--- title: "SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Pacira BioSciences, Inc. (NASDAQ: PCRX)" type: "News" locale: "en" url: "https://longbridge.com/en/news/301512102.md" description: "Monteverde & Associates PC, a class action law firm, has announced an investigation into Pacira BioSciences, Inc. (NASDAQ: PCRX) regarding its proposed sale to Viatris Inc. The transaction would provide shareholders with $36.50 in cash per share. The firm is assessing whether this deal is fair for Pacira's shareholders." datetime: "2026-10-11T16:30:45.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/301512102.md) - [en](https://longbridge.com/en/news/301512102.md) - [zh-HK](https://longbridge.com/zh-HK/news/301512102.md) generator: "portal-rs" --- # SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Pacira BioSciences, Inc. (NASDAQ: PCRX) , /PRNewswire/ -- **Class Action Attorney Juan Monteverde with Monteverde & Associates PC** (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a **Top 50 Firm** in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the **Empire State Building** in New York City and is investigating **Pacira BioSciences, Inc. (NASDAQ: PCRX)** related to its sale to Viatris Inc. Under the terms of the proposed transaction, Pacira shareholders are expected to receive $36.50 in cash per share. **Is it a fair deal?** **Click here for more info** https://monteverdelaw.com/case/pacira-biosciences-inc/. **It is free and there is no cost or obligation to you.** **NOT ALL LAW FIRMS ARE EQUAL.** Before you hire a law firm, you should talk to a lawyer and ask: 1\. Do you file class actions and go to Court? 2\. When was the last time you recovered money for shareholders? 3\. What cases did you recover money in and how much? **About Monteverde & Associates PC** Our firm litigates and has recovered money for shareholders...and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court. **No one is above the law.** If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at \[email protected\] or by telephone at (212) 971-1341. Contact: Juan Monteverde, Esq. MONTEVERDE & ASSOCIATES PC **The Empire State Building** 350 Fifth Ave. Suite 4740 New York, NY 10118 United States of America \[email protected\] Tel: (212) 971-1341 Attorney Advertising. (C) 2026 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter. SOURCE Monteverde & Associates PC ### Related Stocks - [PCRX.US](https://longbridge.com/en/quote/PCRX.US.md) - [VTRS.US](https://longbridge.com/en/quote/VTRS.US.md) ## Related News & Research - [PCRX SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES PACIRA BIOSCIENCES, INC.](https://longbridge.com/en/news/301302554.md) - [Viatris agrees to buy Pacira BioSciences for $36.50 a share in cash, valuing deal at $1.65 billion](https://longbridge.com/en/news/301270461.md) - [Viatris Bets Big on Non-Opioid Painkillers With Pacira Buyout](https://longbridge.com/en/news/301306089.md) - [HC Wainwright & Co. downgrades Pacira BioSciences to Neutral, sets price target to $36.50](https://longbridge.com/en/news/301393942.md) - [Pacira BioSciences SVP Finance Lauren Riker disposes of 6,000 common shares worth $217,920](https://longbridge.com/en/news/301445821.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**